Press Releases and Blog
Blog
Latest Big Pharma Ad Campaign A Potent Reminder Anti-PBM Policies Are Pharma-Backed, Would Increase Pharma Profits At Expense Of Patients, Taxpayers And Employers
This week, Big Pharma announced yet another seven-figure advertising campaign targeting pharmacy benefit managers (PBMs) with false and misleading attacks. This latest Big Pharma investment in
Opposition Continues To Grow Against FTC Interim Report
Momentum against a pre-determined, non-substantive FTC report is gaining steam as Daniel J. Gilman, senior scholar of competition policy with the International Center for Law
FTC Commissioners, Former U.S. Senator And Secretary Of State, Academics, And National Organizations Focused On Fostering Market Forces And Competition React To Flawed FTC Interim Report On PBMs
A former U.S. Senator, a former Secretary of State, academics, national organizations, and two current FTC commissioners raised serious concerns about the Federal Trade Commission’s
JC Scott: Pharmacy Benefit Companies Are More Valuable Now Than Ever
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), discusses the encouraging innovation happening in the pharmacy
Get The Facts: WSJ’s PBM Article Relied On Deeply Flawed Research—In Reality, PBMs Save Patients Billions
The Wall Street Journal recently published an article that, unfortunately, elevated a “study” conducted by an organization, 3 Axis Advisors (46brooklyn), with a long history
ICYMI: Labor Unions And Employers Rely On Pharmacy Benefits For Lower Health Care Costs
In case you missed it, recent media reports have attempted to paint a false picture about pharmacy benefit managers (PBMs). These reports fail to mention
Press Releases
PCMA Urges HELP Committee Lawmakers To Reject False Blame Game, Hold Drug Companies Accountable For Anti-Competitive Practices
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement ahead of a U.S. Senate Committee on Health, Education, Labor, and Pensions
Waltz Health Joins Pharmaceutical Care Management Association
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today announced that Waltz Health is joining the trade association as its newest member. “PCMA is
PCMA Supports Bill to Address Big Pharma’s Patent Thickets
New Bipartisan Legislation would Crack Down on Routine Abuse of the Drug Patent System to Keep More Affordable Alternatives Off Market (Washington, D.C.) — The
PCMA Report Details Increased Costs Associated with Legal Changes in Tennessee
Ever-Broadening Actions Will Increase Prescription Drug Spending by Nearly $5 Billion (Nashville, TN) — The Pharmaceutical Care Management Association (PCMA) today released a report finding that recent
PCMA Statement on CMS Letter to Pharmacy Benefit Companies
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement in response to a letter issued by the Centers for Medicare and Medicaid Services
PCMA Statement On House Vote Of H.R. 5378
The Pharmaceutical Care Management Association (PCMA) released the following statement on the U.S. House of Representatives’ vote on the Lower Costs, More Transparency Act. “America’s
ICYMI: Employers Choose Spread Pricing for a Reason
Millions of Patients Impacted if Option to Use Spread Pricing is Taken Away Pharmacy benefit companies offer employers and health plans flexibility when they’re designing
ICYMI: JAMA Article Affirms Misguided Policies Targeting Pharmacy Benefit Companies Would Weaken Negotiating Power Against Big Pharma, Undercut Savings
A team of professors from Johns Hopkins University, Georgetown Law School, and Utah University College of Pharmacy published in the JAMA Health Forum a paper,
Current And Former Policymakers, Experts Agree Anti-PBM Bills Restrict Free Market, Would Do Nothing To Lower Rx Drug Costs
As Congress considers anti-PBM legislation in the new year, it is important lawmakers are aware that allowing the government to dictate the winners and losers
ICYMI: PCMA Rx Research Corner: In Their Pharmacy Benefit Company Relationships, Employers Have Choice, Flexibility, And The Final Say
In case you missed it, a new PCMA Rx Research Corner blog highlighted the value employers find in their pharmacy benefit company relationships. As Congress
Anti-PBM Bills Would Take Away the Choice and Flexibility Employers Say They Value
Employers overwhelmingly say they’re satisfied with their PBM, describe PBM contracts as “transparent,” and value a wide range of choices from their PBMs A recent
ICYMI: Policymakers And Expert Panel Highlight Negative Consequences Of Misguided Policies Targeting Pharmacy Benefits
In case you missed it, last week’s RealClearPolitics’ virtual event, “The Consequences of Targeting Pharmacy Benefits,” featured policymakers and expert voices exploring the potential negative
Reminder: Conservative Thought Leaders And GOP Lawmakers Oppose Anti-PBM Government Mandates
The U.S. House of Representatives is preparing a suspension vote on the Lower Costs, More Transparency Act, which includes many of the controversial, overreaching proposals
Former Representative Altmire Joins Former U.S. Senator Pat Toomey In Cautioning Lawmakers Against Passing Proposals Targeting Pharmacy Benefits
In case you missed it, Jason Altmire, former Democratic three-term U.S. Representative from Pennsylvania and current adjunct professor at Texas Tech University, explains why so-called
ICYMI: JC Scott In RealClearHealth: Amid Rising Health Care Premiums, Misguided Legislation Would Raise Costs Even Higher
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association, discusses how recent proposals being considered by Congress targeting
ICYMI: Former U.S. Senator Pat Toomey: Before Targeting PBMs, Republicans Should Consider The Unintended Consequences
In case you missed it, Pat Toomey, former U.S. Senator from Pennsylvania, cautioned lawmakers against legislation targeting pharmacy benefit companies and policies that meddle with
